Home › Liver Diseases › Michigan
Liver Diseases clinical trials in Michigan
8 studies for Liver Diseases are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Ann Arbor
- 89bio Clinical Study Site, Clinton Township
- 89bio Clinical Study Site, Detroit
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chesterfield
- 89bio Clinical Study Site, Wyoming
- 89bio Clinical Study Site, Ypsilanti
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06600321Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
- Henry Ford Transplant Institute, Detroit
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT03193151DILIN - Prospective Study
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Apr 8, 2026 · NCT00345930Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
- Henry Ford Health, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Feb 3, 2026 · NCT06269510A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Oct 24, 2025 · NCT05733832From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.